Zobrazeno 1 - 10
of 72
pro vyhledávání: '"N. Marzec"'
Autor:
Ryan T. Borne, Colin O’Donnell, Mintu P. Turakhia, Paul D. Varosy, Cynthia A. Jackevicius, Lucas N. Marzec, Frederick A. Masoudi, Paul L. Hess, Thomas M. Maddox, P. Michael Ho
Publikováno v:
BMC Cardiovascular Disorders, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background The direct oral anticoagulants (DOACs) reduce the risk of stroke in moderate to high-risk patients with non-valvular atrial fibrillation (AF). Yet, concerns remain regarding its routine use in real world practice. We sought to des
Externí odkaz:
https://doaj.org/article/ce1f737b2c2d462d8d619e3d74d1ba47
Autor:
Vinay Kini, Elias J. Dayoub, Paul L. Hess, Lucas N. Marzec, Frederick A. Masoudi, P. Michael Ho, Peter W. Groeneveld
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 6 (2018)
BackgroundScientific statements have championed the measurement of clinical outcomes after cardiac stress testing to better define their value. Using contemporary national data, we sought to describe the characteristics of patients who experience out
Externí odkaz:
https://doaj.org/article/523d0c35691c4a4bb4f734d7958a6549
Autor:
Jehu S. Mathew, Lucas N. Marzec, Kevin F. Kennedy, Philip G. Jones, Paul D. Varosy, Frederick A. Masoudi, Thomas M. Maddox, Larry A. Allen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 8 (2017)
BackgroundAtrial fibrillation (AF) and heart failure with reduced ejection fraction frequently coexist. The AATAC (Ablation versus Amiodarone for Treatment of persistent Atrial fibrillation in patients with Congestive heart failure and an implantable
Externí odkaz:
https://doaj.org/article/fb1ab352b2984935b27802b075e49601
Autor:
William H. Sauer, Paul D. Varosy, Lucas N. Marzec, Ryan T. Borne, Duy T. Nguyen, Nick Mantini, Michael A. Rosenberg
Publikováno v:
Journal of Interventional Cardiac Electrophysiology. 60:469-475
Remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) is standard of care. However, it is underutilized. In July 2012, our institution began providing cell phone adapters (CPAs) to patients free of charge following CIED implantatio
Autor:
James V. Freeman, Lucas N. Marzec, Yue Zheng, Yang Song, Salim S. Virani, Christopher Sciria, Nihar R. Desai, Thomas M. Maddox, Amarnath Annapureddy, Gheorghe Doros, Jane J. Lee, Ali W O’Hare, Christopher P. Cannon, Yuyin Liu, Lina Vadlamani, Ramesh Daggubati, Benjamin Rodwin
Publikováno v:
Clinical Cardiology
Background Previous studies examining the use of direct oral anticoagulants (DOACs) in atrial fibrillation (AF) have largely focused on patients newly initiating therapy. Little is known about the prevalence/patterns of switching to DOACs among AF pa
Autor:
Lucas N. Marzec, John J Lemery, Daniel Bickley, Elaine Reno, Kelly Bookman, Sean S Michael, Christopher Davis, Diana Godfrey, Zachary Blea
Publikováno v:
Telemedicine and e-Health. 25:519-522
Background: Direct-to-consumer virtual visits are increasingly popular across both for-profit and nonprofit healthcare systems. Introduction: Virtual visits offer a convenient affordable w...
Autor:
Johanna Contreras, Javier G. Castillo, Kimberly N. Hong, Thomas M. Maddox, Jonathan C. Hsu, Song Yang, Lucas N. Marzec, Christopher P. Cannon
Publikováno v:
Clinical cardiology, vol 42, iss 3
Clinical Cardiology
Clinical Cardiology
Author(s): Contreras, Johanna P; Hong, Kimberly N; Castillo, Javier; Marzec, Lucas N; Hsu, Jonathan C; Cannon, Christopher P; Yang, Song; Maddox, Thomas M | Abstract: BackgroundIn non-valvular atrial fibrillation (NVAF) patients, congestive heart fai
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lucas N. Marzec, Henry H. Ting, Jonathan C. Hsu, Kensey Gosch, Thomas M. Maddox, Paul S. Chan, Jingyan Wang, Nilay Shah
Publikováno v:
Journal of the American College of Cardiology. 69:2475-2484
Oral anticoagulation (OAC) with warfarin is underused for atrial fibrillation (AF). The availability of direct oral anticoagulants (DOACs) may improve overall OAC rates in AF patients, but a large-scale evaluation of their effects has not been conduc
Autor:
Yang Song, Gheorghe Doros, Salim S. Virani, Mark Y. Jeong, Spero M. Manson, Jonathan C. Hsu, Thomas M. Maddox, Lucas N. Marzec, Umair Khalid, Liyan Dong, Nicholas Mantini, Christopher P. Cannon
Publikováno v:
Journal of the American College of Cardiology. 75:2749-2750
Globally, atrial fibrillation (AF) is a major cause of death and disability. Unfortunately, despite the wide availability of AF treatments, racial differences in their provision exist. One racial group that has been relatively understudied is America